Abrha, A., Shukla, N. D., Hodan, R., Longacre, T., Raghavan, S., Pritchard, C. C., ... Haraldsdottir, S. (2020). Universal Screening of Gastrointestinal Malignancies for Mismatch Repair Deficiency at Stanford.
JNCI cancer spectrum,
4(5), pkaa054.
Al Sahaf, O., Myers, E., Jawad, M., Browne, T. J., Winter, D. C., & Redmond, H. P. (2011). The prognostic significance of extramural deposits and extracapsular lymph node invasion in colon cancer.
Diseases of the Colon and Rectum,
54(8), 982-8.
Beaton, C., Twine, C. P., Williams, G. L., & Radcliffe, A. G. (2013). Systematic review and meta-analysis of histopathological factors influencing the risk of lymph node metastasis in early colorectal cancer.
Colorectal Disease,
15(7), 788-97.
Bentzen, S. M., Balslev, I., Pedersen, M., Teglbjaerg, P. S., Hanberg-Sorensen, F., Bone, J., ... et al. (1992). Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis.
British Journal of Cancer,
65(1), 102-7.
Betge, J., Pollheimer, M. J., Lindtner, R. A., Kornprat, P., Schlemmer, A., Rehak, P., ... Langner, C. (2012). Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting.
Cancer,
118(3), 628-38.
Bosch, S. L., Teerenstra, S., de Wilt, J. H., Cunningham, C., & Nagtegaal, I. D. (2013). Predicting lymph node metastasis in pT1 colorectal cancer: a systematic review of risk factors providing rationale for therapy decisions.
Endoscopy,
45(10), 827-34.
Burgart, L. J., Shi, C., Berho, M. E., Driman, D. K., Fitzgibbons, P., Frankel, W. L., Hill, K. A., Jessup, J., Kakar, S., Krasinskas, A. M., Washington, M. K. (2020).
Protocol for the Examination of Excisional Biopsy Specimens From Patients With Primary Carcinoma of the Colon and Rectum. (Version 4.1.0.0). Northfield, Illinois: College of American Pathologists. Hentet fra
https://documents.cap.org/protocols/cp-gilower-colonrectum-biopsy-20-4100.pdf
Caputo, D., Caricato, M., La Vaccara, V., Taffon, C., Capolupo, G. T., & Coppola, R. (2014). T1 colorectal cancer: poor histological grading is predictive of lymph-node metastases.
International Journal of Surgery (London, England),
12(3), 209-12.
Cercek, A., Lumish, M., Sinopoli, J., Weiss, J., Shia, J., Lamendola-Essel, M., ... Diaz, L. A. ,. J. (2022). PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer.
New England Journal of Medicine,
386(25), 2363-2376.
Cervantes, A., Adam, R., Roselló, S., Arnold, D., Normanno, N., Taïeb, J., ... Martinelli, E. (2023). Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Annals of Oncology,
34(1), 10-32.
Chalabi, M., Fanchi, L. F., Dijkstra, K. K., Van den Berg, J. G., Aalbers, A. G., Sikorska, K., ... Haanen, J. B. (2020). Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers.
Nature Medicine,
26(4), 566-576.
Chalabi, M., Verschoor, Y. L., van den Berg, J., Sikorska, K., Beets, G., Lent, A. V., ... Haanen, J. B. A. G. (2022). LBA7 Neoadjuvant immune checkpoint inhibition in locally advanced MMR-deficient colon cancer: The NICHE-2 study.
Annals of Oncology,
33(Suppl 7), S1389.
Den norske legeforening (2012).
Veileder i biopsibesvarelse av maligne svulster. (2 utg.). Oslo.
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pages, C., ... Pages, F. (2006). Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.
Science,
313(5795), 1960-1964.
Haddad, T. S., Lugli, A., Aherne, S., Barresi, V., Terris, B., Bokhorst, J. M., ... Nagtegaal, I. D. (2021). Improving tumor budding reporting in colorectal cancer: a Delphi consensus study.
Virchows Archiv,
479(3), 459-469.
Haggitt, R. C., Glotzbach, R. E., Soffer, E. E., & Wruble, L. D. (1985). Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy.
Gastroenterology,
89(2), 328-36.
Haugland, H. K., Casati, B., Dorum, L. M., & Bjugn, R. (2011). Template reporting matters--a nationwide study on histopathology reporting on colorectal carcinoma resections.
Human Pathology,
42(1), 36-40.
Japanese Society for Cancer of the Colon and Rectum (2019). Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma: the 3d English Edition [Secondary Publication].
Journal of the anus, rectum and colon,
3(4), 175-195.
Koren, R., Siegal, A., Klein, B., Halpern, M., Kyzer, S., Veltman, V., & Gal, R. (1997). Lymph node-revealing solution: simple new method for detecting minute lymph nodes in colon carcinoma.
Diseases of the Colon and Rectum,
40(4), 407-10.
Kouyama, Y., Kudo, S. E., Miyachi, H., Ichimasa, K., Hisayuki, T., Oikawa, H., ... Hamatani, S. (2016). Practical problems of measuring depth of submucosal invasion in T1 colorectal carcinomas.
International Journal of Colorectal Disease,
31(1), 137-46.
Leijssen, L. G. J., Dinaux, A. M., Amri, R., Taylor, M. S., Deshpande, V., Bordeianou, L. G., ... Berger, D. L. (2019). Impact of intramural and extramural vascular invasion on stage II-III colon cancer outcomes.
Journal of Surgical Oncology,
119(6), 749-757.
Liebig, C., Ayala, G., Wilks, J., Verstovsek, G., Liu, H., Agarwal, N., ... Albo, D. (2009). Perineural invasion is an independent predictor of outcome in colorectal cancer.
Journal of Clinical Oncology,
27(31), 5131-7.
Loughrey, M. B., Arends, M., Brown, I., Burgart, L. J., Cunningham, C., Flejou, J. F., Kakar, S., Kirsch, R., Kojima, M., Lugli, A., Rosty, C., Sheahan, K., West, N. P., Wilson, R., Nagtegaal, I. D. (2020).
Colorectal Cancer Histopathology Reporting Guide. (1 utg.). Sydney: International Collaboration on Cancer Reporting. Hentet fra
https://www.iccr-cancer.org/wp-content/uploads/2023/08/ICCR-Colorectal-1st-edn-v1.0-bookmark.pdf
Loughrey, M. B., Kent, O., Moore, M., Coghlin, C., Kelly, P., McVeigh, G., & Coleman, H. G. (2020). Impact on colorectal cancer pathology reporting practice of migration from TNM 5 to TNM 8.
Histopathology,
77(2), 210-222.
Lugli, A., Kirsch, R., Ajioka, Y., Bosman, F., Cathomas, G., Dawson, H., ... Quirke, P. (2017). Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.
Modern Pathology,
30(9), 1299-1311.
Nagtegaal, I. D., & van Krieken, J. H. (2002). The role of pathologists in the quality control of diagnosis and treatment of rectal cancer-an overview.
European Journal of Cancer,
38(7), 964-72.
Nakadoi, K., Tanaka, S., Kanao, H., Terasaki, M., Takata, S., Oka, S., ... Chayama, K. (2012). Management of T1 colorectal carcinoma with special reference to criteria for curative endoscopic resection.
Journal of Gastroenterology and Hepatology,
27(6), 1057-62.
Newell, K. J., Sawka, B. W., Rudrick, B. F., & Driman, D. K. (2001). GEWF solution.
Archives of Pathology and Laboratory Medicine,
125(5), 642-5.
Norderval, S., Solstad Ø, B., Hermansen, M., & Steigen, S. E. (2016). Increased lymph node retrieval decreases adjuvant chemotherapy rate for stage II colon cancer.
Scandinavian Journal of Gastroenterology,
51(8), 949-55.
Pages, F., Berger, A., Camus, M., Sanchez-Cabo, F., Costes, A., Molidor, R., ... Galon, J. (2005). Effector memory T cells, early metastasis, and survival in colorectal cancer.
New England Journal of Medicine,
353(25), 2654-66.
Papke, D. J. ,. J., Yurgelun, M. B., Noffsinger, A. E., Turner, K. O., Genta, R. M., & Redston, M. (2022). Prevalence of Mismatch-Repair Deficiency in Rectal Adenocarcinomas.
New England Journal of Medicine,
387(18), 1714-1716.
Rosty, C., Brown, I., Cooper, H., Dekker, E., Driman, D. K., Gonzalez, R. S., Hewett, D. G., Loughrey, M. B., Makinen, M., Pai, R., Sheahan, K., Nagtegaal, I. D. (2020).
Colorectal Excisional Biopsy (Polypectomy) Histopathology Reporting Guide. Sydney: International Collaboration on Cancer Reporting. Hentet fra
https://www.iccr-cancer.org/datasets/published-datasets/digestive-tract/colorectal-polypectomy/
Ryan, R., Gibbons, D., Hyland, J. M., Treanor, D., White, A., Mulcahy, H. E., ... Sheahan, K. (2005). Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Histopathology,
47(2), 141-6.
Sepulveda, A. R., Hamilton, S. R., Allegra, C. J., Grody, W., Cushman-Vokoun, A. M., Funkhouser, W. K., ... Nowak, J. A. (2017). Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline Summary From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.
Journal of Oncology Practice,
13(5), 333-337.
Sinicrope, F. A., & Sargent, D. J. (2012). Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implications.
Clinical Cancer Research,
18(6), 1506-12.
Smith, K. D., Tan, D., Das, P., Chang, G. J., Kattepogu, K., Feig, B. W., ... Rodriguez-Bigas, M. A. (2010). Clinical significance of acellular mucin in rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation.
Annals of Surgery,
251(2), 261-4.
Sobin, L. H., Gospodarowicz, M., & Wittekind, C. (2016).
TNM: classification of malignant tumors. Wiley-Blackwell.
Suzuki, H., Fujii, T., Asao, T., Tsutsumi, S., Wada, S., Araki, K., ... Kuwano, H. (2014). Extracapsular lymph node involvement is associated with colorectal liver metastases and impact outcome after hepatectomy for colorectal metastases.
World Journal of Surgery,
38(8), 2079-88.
Tasi, C. K., Chen, C. Y., Liu, C. Y., & Wu, Y. Y. (2012). Reliability and effectiveness of GEWF solution in the identification of lymph nodes in specimens of colorectal carcinoma.
International Journal of Surgical Pathology,
20(6), 589-95.
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., de la Chapelle, A., Ruschoff, J., ... Srivastava, S. (2004). Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.
Journal of the National Cancer Institute,
96(4), 261-8.
Valtorta, E., Martino, C., Sartore-Bianchi, A., Penaullt-Llorca, F., Viale, G., Risio, M., ... Gambacorta, M. (2015). Assessment of a HER2 scoring system for colorectal cancer: results from a validation study.
Modern Pathology,
28(11), 1481-91.
Van Cutsem, E., Cervantes, A., Nordlinger, B., & Arnold, D. (2014). Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of Oncology,
25 Suppl 3, iii1-9.
WHO Classification of Tumorous Editorial Board (2019).
Digestive System Tumours. International Agency for Reasearch on Cancer.
Wijesuriya, R. E., Deen, K. I., Hewavisenthi, J., Balawardana, J., & Perera, M. (2005). Neoadjuvant therapy for rectal cancer down-stages the tumor but reduces lymph node harvest significantly.
Surgery Today,
35(6), 442-5.
Zwager, L. W., Bastiaansen, B. A. J., Montazeri, N. S. M., Hompes, R., Barresi, V., Ichimasa, K., ... Dekker, E. (2022). Deep Submucosal Invasion Is Not an Independent Risk Factor for Lymph Node Metastasis in T1 Colorectal Cancer: A Meta-Analysis.
Gastroenterology,
163(1), 174-189.